{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:36:28Z","timestamp":1767972988101,"version":"3.49.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fund of Key Laboratory of Myocardial Ischemia, Ministry of Education of China","award":["KF201919"],"award-info":[{"award-number":["KF201919"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Thymic epithelial tumors (TETs), originating from the thymic epithelial cells, are the most common primary neoplasms of the anterior mediastinum. Emerging evidence demonstrated that the competing endogenous RNAs (ceRNAs) exerted a crucial effect on tumor development. Hence, it is urgent to understand the regulatory mechanism of ceRNAs in TETs and its impact on tumor prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>TETs datasets were harvested from the UCSC Xena as the training cohort, followed by differentially expressed mRNAs (DEmRNAs), lncRNAs (DElncRNAs), and miRNAs (DEmiRNAs) at different pathologic type (A, AB, B, and TC) identified via DESeq2 package. clusterProfiler package was utilized to carry out gene ontology and Kyoto encyclopedia of genes and genomes functional analysis on the DEmRNAs. Subsequently, the lncRNA-miRNA-mRNA regulatory network was constructed to screen the key DEmRNAs. After the key DEmRNAs were verified in the external cohort from Gene Expression Omnibus database, their associated-ceRNAs modules were used to perform the K-M and Cox regression analysis to build a prognostic significance for TETs. Lastly, the feasibility of the prognostic significance was validated by receiver operating characteristic (ROC) curves and the area under the curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Finally, a total of 463 DEmRNAs, 87 DElncRNAs, and 20 DEmiRNAs were obtained from the intersection of differentially expressed genes in different pathological types of TETs. Functional enrichment analysis showed that the DEmRNAs were closely related to cell proliferation and tumor development. After lncRNA-miRNA-mRNA network construction and external cohort validation, a total of 4 DEmRNAs DOCK11, MCAM, MYO10, and WASF3 were identified and their associated-ceRNA modules were significantly associated with prognosis, which contained 3 lncRNAs (lncRNA LINC00665, lncRNA NR2F1-AS1, and lncRNA RP11-285A1.1), 4 mRNAs (DOCK11, MCAM, MYO10, and WASF3), and 4 miRNAs (hsa-mir-143, hsa-mir-141, hsa-mir-140, and hsa-mir-3199). Meanwhile, ROC curves verified the accuracy of prediction ability of the screened ceRNA modules for prognosis of TETs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our study revealed that ceRNAs modules might exert a crucial role in the progression of TETs. The mRNA associated-ceRNA modules could effectively predict the prognosis of TETs, which might be the potential prognostic and therapeutic markers for TETs patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026271","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T14:00:09Z","timestamp":1623938409000},"page":"e26271","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors"],"prefix":"10.1097","volume":"100","author":[{"given":"Kegong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University"},{"name":"Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University"},{"name":"Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University"},{"name":"Department of Chest Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First Hospital of Harbin, Harbin Institute of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-1293","authenticated-orcid":false,"given":"Guanghua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization Classification of Tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"(10 Suppl 4)","key":"R2-20250504","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1097\/JTO.0b013e3181f209a8","article-title":"Thymoma and thymic carcinoma: molecular pathology and targeted therapy","volume":"5","author":"Strobel","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00109-014-1165-y","article-title":"Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer","volume":"92","author":"Gower","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"(10 Suppl 4)","key":"R6-20250504","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1097\/JTO.0b013e3181f21114","article-title":"Targeted therapy for advanced thymic tumors","volume":"5","author":"Rajan","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R7-20250504","first-page":"83","article-title":"MicroRNAs: processing, maturation, target recognition and regulatory functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol Cell Pharmacol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell"},{"key":"R9-20250504","first-page":"05","article-title":"Registered report: coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","author":"Phelps","year":"2016","journal-title":"Elife"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","article-title":"ceRNA in cancer: possible functions and clinical implications","volume":"52","author":"Qi","year":"2015","journal-title":"J Med Genet"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-015-0129-1","article-title":"Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics","volume":"8","author":"Sanchez-Mejias","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.2147\/OTT.S147717","article-title":"Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia","volume":"10","author":"Huang","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.lungcan.2012.11.015","article-title":"Reproducibility of the WHO classification of thymomas: practical implications","volume":"79","author":"Zucali","year":"2013","journal-title":"Lung Cancer"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ejcts\/ezv288","article-title":"Surgical treatment of thymoma: an 11-year experience with 761 patients","volume":"49","author":"Zhao","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"(10 Suppl 4)","key":"R19-20250504","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1097\/JTO.0000000000000363","article-title":"Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging","volume":"9","author":"Litvak","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1177\/1078155219835597","article-title":"Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer","volume":"25","author":"KM","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1158\/1078-0432.CCR-17-0066","article-title":"Genomic analysis of thymic epithelial tumors identifies novel subtypes associated with distinct clinical features","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"244.e210","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15384047.2015.1108493","article-title":"Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors","volume":"17","author":"Bellissimo","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-017-0655-2","article-title":"Thymic epithelial tumors phenotype relies on miR-145-5p epigenetic regulation","volume":"16","author":"Bellissimo","year":"2017","journal-title":"Mol Cancer"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11748-012-0160-x","article-title":"Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies","volume":"60","author":"Omatsu","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41419-019-1361-3","article-title":"Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98","volume":"10","author":"Cong","year":"2019","journal-title":"Cell Death Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.18632\/aging.102563","article-title":"Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p","volume":"11","author":"Li","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2605.2007.00758.x","article-title":"Improved gene expression signature of testicular carcinoma in situ","volume":"30","author":"Almstrup","year":"2007","journal-title":"Int J Androl"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ijc.32911","article-title":"Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells","volume":"147","author":"Zeng","year":"2020","journal-title":"Int J Cancer"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.18632\/oncotarget.3135","article-title":"NF-kappaB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10","volume":"6","author":"Sun","year":"2015","journal-title":"Oncotarget"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/onc.2015.527","article-title":"WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2\/HER3 signaling","volume":"35","author":"Teng","year":"2016","journal-title":"Oncogene"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:41:52Z","timestamp":1746337312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":33,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026271","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"2020-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}